February 2021 – Page 2 – Policy & Medicine

Drug Manufacturers Sue HHS Over 340B Advisory Opinion

Variation Abounds in Hospital Price Transparency Rule Implementation

New Final Rule in Effect Updating AKS Safe Harbors

Price Transparency Rule Given the Green Light by D.C. Court of Appeals

CMS Announces New Voluntary Payment Model

PhRMA Sues Over “Unconstitutional” 340B Rule

What Does the Consolidated Appropriations Act Mean to Industry?

Trump Administration Makes Final Proposed Rule Push

FDA Issues Draft Guidance on Proprietary Names

Several States Work Together, Reach $40 Million Settlement with Apria Healthcare